Literature DB >> 22571097

Prevalence of autistic spectrum disorders in Tripoli, Libya: the need for more research and planned services.

A M Zeglam1, A J Maound.   

Abstract

Data on autism are lacking for Libya. We conducted a hospital-based study in the Neurodevelopment Clinic of AI-Khadra Hospital in Tripoli to estimate the prevalence of autistic spectrum disorders in children attending the clinic. All children referred to the clinic between 2005 and 2009 with a diagnosis of speech and language disorders or behavioural difficulties were assessed. There were 38 508 children in total seen during 2005-09,180 of whom had a history of delayed speech and language and/or behavioural difficulties. Of the 180, 128 children were diagnosed with autistic spectrum disorder: 99 had classical autism, giving the prevalence of about 4 in 1000. The male:female ratio for autistic spectrum disorders was 4:1 and for autism was 4.5:1. The most common age at presentation was 2-5 years (58%) and 56% presented 6-18 months after the onset of symptoms. Physicians should consider autism in the differential diagnosis of any child presenting with a speech and language disorder and/or behavioural difficulties.

Entities:  

Mesh:

Year:  2012        PMID: 22571097     DOI: 10.26719/2012.18.2.184

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Dental caries experience and periodontal treatment needs of children with autistic spectrum disorder.

Authors:  S Fakroon; A Arheiam; S Omar
Journal:  Eur Arch Paediatr Dent       Date:  2014-11-11

2.  "On the Sidelines": Access to Autism-Related Services in the West Bank.

Authors:  Sarah Dababnah; Kathleen Bulson
Journal:  J Autism Dev Disord       Date:  2015-12

3.  The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Shabnam Rasoulpoor; Shna Rasoulpoor; Shamarina Shohaimi; Sima Jafarpour; Nasrin Abdoli; Behnam Khaledi-Paveh; Masoud Mohammadi
Journal:  Ital J Pediatr       Date:  2022-07-08       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.